Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 1998
An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma
J M Michon, O Hartmann, E Bouffet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)
H Rubie, O Delattre, O Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis
D Frappaz, J Michon, C Coze, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
July 27, 2000
[Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists]
D Plantaz, J Michon, D Valteau-Couanet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry
R Ladenstein, T Philip, C Lasset, et al.
Annals of Internal Medicine
|
April 15, 1997
Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial
O Hartmann, A G Le Corroller, D Blaise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90
J Landman-Parker, H Pacquement, T Leblanc, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
November 26, 2015
[Multidisciplinarity, education, and training in pediatric oncology-hematology]
G Vassal, J Landman-Parker, A Baruchel, et al.
Hepatology International
|
September 10, 2021
Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies
M Illiano, M Colinard, S Taque, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology
C Coze, O Hartmann, J Michon, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 1998
An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma
J M Michon, O Hartmann, E Bouffet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)
H Rubie, O Delattre, O Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis
D Frappaz, J Michon, C Coze, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
July 27, 2000
[Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists]
D Plantaz, J Michon, D Valteau-Couanet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry
R Ladenstein, T Philip, C Lasset, et al.
Annals of Internal Medicine
|
April 15, 1997
Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial
O Hartmann, A G Le Corroller, D Blaise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90
J Landman-Parker, H Pacquement, T Leblanc, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
November 26, 2015
[Multidisciplinarity, education, and training in pediatric oncology-hematology]
G Vassal, J Landman-Parker, A Baruchel, et al.
Hepatology International
|
September 10, 2021
Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies
M Illiano, M Colinard, S Taque, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology
C Coze, O Hartmann, J Michon, et al.
Page
of 7